Recently, high levels of BCYRN1 in breast cancer tissues, esophageal squamous cell carcinoma tissues and non-small-cell lung cancer tissues have been observed [16–18]. This evidence concerns the gene BCYRN1 and esophageal squamous cell carcinoma.